Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 29
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Elevance Health Inc
ELV
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$414.50
-6.99
-1.66%
Ult. Agg.: Oct 28, 5:24 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Elevance Health Financials
Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International, Thermo Fisher
Benzinga Insights
PRO
Elevance Health FY2026 Adj EPS expected to be more than $29.00 vs $27.23 Est
Elevance Health (NYSE:ELV) FY2026 expected to be more than $29.00 vs $27.23 Est..
Benzinga Newsdesk
PRO
Elevance Health FY2026 GAAP EPS expected to be more than $22.00 vs $20.74 Est
Elevance Health (NYSE:ELV) FY2026 expected to be more than $22.00 vs $20.74 Est..
Benzinga Newsdesk
PRO
Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate
Elevance Health (NYSE:ELV) reported quarterly earnings of $6.99 per share which beat the analyst consensus estimate of $4.68 by 49.36 percent. This is a 15.92 percent increase over earnings of $6.03 per share from the
Benzinga Newsdesk
PRO
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..
Benzinga Newsdesk
PRO
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..
Benzinga Newsdesk
